Annual report
4626.TEDINET S100YBLG
Period2025-04-01 → 2026-03-31
Filed2026-06-16
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥137.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥119.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥104.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥97.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥98.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥32.5bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥22.1bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥32.2bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥21.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.3bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.5bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.1bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥32.1bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥14.6bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥24.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.7bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.8bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥24.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥10.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥201.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥192.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥212.8bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥187.3bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥189.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥86.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥89.0bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥115.8bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥103.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥100.4bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥92.7bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥85.5bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥43.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥44.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥42.5bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥44.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥57.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥47.1bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥51.2bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥30.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥21.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥22.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥18.3bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥21.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥26.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥29.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥9.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥13.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥215.92 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥96.59 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.44 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.86 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥104.56 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,040.16 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥927.34 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥897.57 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥831.62 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥761.06 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 57.3% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 22.0% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.0% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.6% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,561 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 2,485 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 2,210 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 2,120 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 2,137 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥27.1bn | 2025-04-01 → 2026-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥23.6bn | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥15.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥14.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥18.0bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥15.2bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥18.6bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥14.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.9bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.6bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.0bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥17.6bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥9.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥18.3bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥10.2bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥6.1bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.5bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥113.8bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥118.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥132.7bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥116.6bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥128.7bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥50.8bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥58.4bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥63.1bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥59.6bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥55.7bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥54.0bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥52.7bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥13.5bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥17.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥164.55 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.09 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.22 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.82 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.44 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥165 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥190 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥89 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥69.55 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥566.78 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥536.53 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥497.64 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥483.96 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥469.43 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.4% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.9% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.0% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 29.8% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 116,839,616 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 116,739,010 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 116,583,118 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 116,371,002 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 116,166,256 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 176 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 171 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 156 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 143 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 154 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 67
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2025-04-01 → 2026-03-31 | ¥556m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥544m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 560 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2026-03-31 | ¥6.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥6.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥407m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2026-03-31 | ¥10.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | −¥95m |
| Electronics Materialsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥6.0bn |
| Electronics Materialsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3.7bn |
| Electronics Materialsreportable segment | employees | at 2026-03-31 | 1383 pure |
| Electronics Materialsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥95.3bn |
| Electronics Materialsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥95.3bn |
| Electronics Materialsreportable segment | segment assets | at 2026-03-31 | ¥97.8bn |
| Electronics Materialsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥29.2bn |
| Medical And Pharmaceuticalreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥1.8bn |
| Medical And Pharmaceuticalreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3.6bn |
| Medical And Pharmaceuticalreportable segment | employees | at 2026-03-31 | 618 pure |
| Medical And Pharmaceuticalreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥36.5bn |
| Medical And Pharmaceuticalreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥36.5bn |
| Medical And Pharmaceuticalreportable segment | segment assets | at 2026-03-31 | ¥61.9bn |
| Medical And Pharmaceuticalreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥5.1bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥7.8bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥7.3bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥131.8bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥131.8bn |
| —segment total | segment assets | at 2026-03-31 | ¥159.7bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥34.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥7.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥138.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥137.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥407m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥170.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥34.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥436m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥5.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥406m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥262m |
| Electronics Materialsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.6bn |
| Electronics Materialsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3.6bn |
| Electronics Materialsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥81.7bn |
| Electronics Materialsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥81.7bn |
| Electronics Materialsreportable segment | segment assets | at 2025-03-31 | ¥87.4bn |
| Electronics Materialsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥21.5bn |
| Medical And Pharmaceuticalreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Medical And Pharmaceuticalreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥4.5bn |
| Medical And Pharmaceuticalreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥31.6bn |
| Medical And Pharmaceuticalreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥31.6bn |
| Medical And Pharmaceuticalreportable segment | segment assets | at 2025-03-31 | ¥64.1bn |
| Medical And Pharmaceuticalreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥3.8bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥8.2bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥113.3bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥113.3bn |
| —segment total | segment assets | at 2025-03-31 | ¥151.5bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥23.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥119.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥119.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥406m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥162.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥23.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,652
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00913-000SatoIkumiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E00913-000MaruyamaMisaeMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant | 383000 | |
| Audit fees reporting company | Prior1YearDuration | 93000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 73000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 31000000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | 35000000 | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 124000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 108000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Audit fees reporting company network firms | Prior1YearDuration | － | JPY |
| Non audit fees reporting company network firms | Prior1YearDuration | － | JPY |
| Audit fees reporting company network firms | CurrentYearDuration | － | JPY |
| Non audit fees reporting company network firms | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries network firms | Prior1YearDuration | 36000000 | JPY |
| Non audit fees consolidated subsidiaries network firms | Prior1YearDuration | 5000000 | JPY |
| Audit fees consolidated subsidiaries network firms | CurrentYearDuration | 36000000 | JPY |
| Non audit fees consolidated subsidiaries network firms | CurrentYearDuration | 5000000 | JPY |
| Audit fees total network firms | Prior1YearDuration | 36000000 | JPY |
| Non audit fees total network firms | Prior1YearDuration | 5000000 | JPY |
| Audit fees total network firms | CurrentYearDuration | 36000000 | JPY |
| Non audit fees total network firms | CurrentYearDuration | 5000000 | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 354000000 | JPY |
| Liquidated account remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 49000000 | JPY |
| Performance linked monetary compensation etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 41000000 | JPY |
| Performance linked stock compensation etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 220000000 | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 42000000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsExcludingAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 3 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersMember | 22000000 | JPY |
| Liquidated account remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersMember | 22000000 | JPY |
| Performance linked monetary compensation etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Performance linked stock compensation etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E00913-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersMember | 2 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 60000000 | JPY |
| Liquidated account remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 60000000 | JPY |
| Performance linked monetary compensation etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Performance linked stock compensation etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 4 | |
| Total amount of remuneration etc paid by group remuneration etc paid by group to each director or other officer | CurrentYearDuration_jpcrp030000-asr_E00913-000SaitoHitoshiMember | 347000000 | JPY |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | － | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 1 | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 88000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |